pharmaceuticals

As the supply chain becomes increasingly complex, technology is growing more sophisticated to keep up. Connected intelligence company CalAmp on Thursday announced a new offering, the iOn Xtreme Temperature Tag, a smart sensor tag that can pair with a thermocouple probe to measure assets in extreme...

Moderna Inc (NASDAQ: MRNA) shares are reversing course and are higher Tuesday. UK Expands Authorization: The UK drug regulator — the Medicines and Healthcare Products Regulatory Agency — announced Tuesday it has expanded the authorization given to Moderna's...

Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 34.3%. But there is no question some big-name stocks performed better than others along the way. Johnson & Johnson’...

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta variant has been spreading throughout the U.S. Inovio Pharmaceuticals was up 13.45% at $9.70 at last check...

Moderna Inc (NASDAQ: MRNA), a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc (NYSE: MRK) in terms of market capitalization. What Happened: Moderna’s shares spiked Monday amid a string of positive news including being granted provisional registration...

Moderna Inc (NASDAQ: MRNA) shares traded higher Thursday after the company reported better-than-expected earnings per share and sales results. The company reported earnings per share of $6.46, beating the $6.04 estimate. Sales results came in at $4.4 billion, beating the estimate of $4.28...

Novo Nordisk A/S (NYSE: NVO) shares traded higher by 3.2% on Thursday morning after the insulin and diabetes care leader landed a major Wall Street upgrade. The Analyst: Bank of America analyst Sachin Jain upgraded Novo Nordisk from Neutral to Buy and raised his price target from $100.27 to $117.04...

The recent downturn in Incyte Corporation’s (NASDAQ: INCY) share price offers an entry opportunity, with the FDA likely to approve ruxolitinib in chronic GVHD indication in September 2021, according to Benchmark. The Incyte Analyst: Aydin Huseynov upgraded the rating for Incyte to Buy, while...

Atossa Therapeutics Inc (NASDAQ: ATOS) shares are trading higher Tuesday after retail traders were able to push the stock higher. The stock was trading on above-average volume Tuesday and was trending on social media sites throughout the day such as StockTwits. Atossa Therapeutics was up 13.42...

180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher Monday after the company announced it regained compliance with the Nasdaq. The company was notified Jan. 6 it did not meet the listing requirements for the Nasdaq. The company then provided reasoning why it should regain...

Marlboro cigarette maker Philip Morris International Inc. (NYSE: PM) announced Friday a deal that would give a further thrust to its "Beyond Nicotine" strategy. The Philip Morris-Vectura Deal Terms: New York-based Philip Morris said it has agreed with the board of Vectura Group plc (OTC...

The sell-off on shares of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) tied to the ARO-EnAC phase 1/2 study halt is overdone, leading H.C. Wainwright & Co. to reiterate its Buy rating. The Arrowhead Analyst: H.C. Wainwright & Co. analyst Patrick Trucchio reiterated the firm...

Regeneron Pharmaceuticals Inc.'s (NASDAQ: REGN) robust pipeline and attractive valuation has prompted an analyst at HC Wainwright to join the bullish camp. The Regeneron Analyst: Analyst Michael King initiated coverage of Regeneron shares with a Buy rating and a $703 price target. The...

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ: BIIB) stock earlier this month when its Alzheimer's treatment Aduhelm was approved. Details on key catalytic events...

Tilray Inc (NASDAQ: TLRY) broke bullish from a triangle on May 25 and on Wednesday its stock had bullish continuation. The move could be due to one or more of the following possibilities: Renewed interest in the cannabis sector: A couple of the larger Canadian cannabis companies have seen...